ログイン

LMR 12

LMR 12
100問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    Protein A: (2)

    Staphylococcus aureus, coagglutination

  • 2

    Slime layer production:

    Staphylococcus epidermidis

  • 3

    Protein ?: Streptococcus pyogenes

    M

  • 4

    Protein M: ?

    Streptococcus pyogenes

  • 5

    Colonies with ground glass appearance: ? (Mahon)

    Legionella

  • 6

    Increased resistance of Pseudomonas aeruginosa to aminoglycosides: Increased ? and ?

    calcium and magnesium

  • 7

    Increased resistance of ? to aminoglycosides: Increased calcium and magnesium

    Pseudomonas aeruginosa

  • 8

    Increased resistance of Pseudomonas aeruginosa to ?: Increased calcium and magnesium

    aminoglycosides

  • 9

    Smallest free-living organism:

    Mycoplasma

  • 10

    . : Comparison with peers

    Benchmarking

  • 11

    Histoplasma crossreacts with:

    BAC Blastomyces, Aspergillus and Coccidioides

  • 12

    Aman medium stain:

    Lactophenol cotton blue

  • 13

    ? stain: Lactophenol cotton blue

    Aman medium

  • 14

    Czapek’s medium: Isolation of ?

    Aspergillus

  • 15

    ? medium: Isolation of Aspergillus

    Czapek’s

  • 16

    African histoplasmosis:

    Histoplasma duboisii

  • 17

    : Histoplasma duboisii

    African histoplasmosis

  • 18

    Test for Candida albicans that uses serum:

    Germ tube test

  • 19

    Test for ? that uses serum: Germ tube test

    Candida albicans

  • 20

    Chlamydospore production of Candida albicans:

    Cornmeal agar

  • 21

    Chlamydospore production of ? Cornmeal agar

    Candida albicans:

  • 22

    ? production of Candida albicans: Cornmeal agar

    Chlamydospore

  • 23

    Candidiasis infection affecting the oral cavity:

    Thrush

  • 24

    ? infection affecting the oral cavity: Thrush

    Candidiasis

  • 25

    General isolation media for fungi:

    Saboraud’s dextrose agar

  • 26

    General isolation media for ?: Saboraud’s dextrose agar

    fungi

  • 27

    Major biologic hazard to laboratory personnel: ?

    Coccidioides immitis

  • 28

    Sensitive fungal (fluorescent) dye that binds to cell wall:

    Calcofluor white

  • 29

    Chromoblastomycosis:

    Sclerotic bodies

  • 30

    : Sclerotic bodies

    Chromoblastomycosis

  • 31

    Rose gardener’s disease:

    Sporotrichosis

  • 32

    Eosinophilic material due to antigen-antibody reaction in cases of sporotrichosis:

    Asteroid body

  • 33

    Largest DNA virus:

    Poxvirus

  • 34

    Smallest DNA virus:

    Parvovirus

  • 35

    Largest RNA virus:

    Paramyxovirus

  • 36

    . Smallest RNA virus:

    Enterovirus (Picornaviridae)

  • 37

    Cross reactive antigen in all human adenoviruses:

    Hexon

  • 38

    Gastroenteritis in children during winter months:

    Rotavirus

  • 39

    Nonbacterial gastroenteritis in adults:

    Norovirus

  • 40

    Toxic to HSV:

    Calcium alginate

  • 41

    Isolation medium for Cytomegalovirus:

    Human fibroblast cells

  • 42

    True amoeba:

    GENUS Entamoeba

  • 43

    Trophozoite with ingested red blood cell:

    Entamoeba histolytica

  • 44

    Trophozoite with ingested WBC:

    Entamoeba gingivalis

  • 45

    . Gay bowel syndrome:

    Giardiasis

  • 46

    Cercaria minus a tail:

    Schistosomule

  • 47

    Infective stage of Diphyllobothrium latum:

    Plerocercoid larva

  • 48

    . Resembles Diphyllobothrium latum adult:

    Spirometra

  • 49

    Passing of proglottids of Taenia: Irritated by ?

    ALCOHOL

  • 50

    ?. eggs: Hexacanth embryo with thick radial striations

    Taenia spp

  • 51

    Cercarial dermatitis: ?

    Schistosomes

  • 52

    Length of needle in routine phlebotomy:

    1.0 – 1.5 inches

  • 53

    Angle of draw in venipuncture:

    15 to 30 ° angle (15 degree angle)

  • 54

    The distance of drop of blood from the edge of the slide:

    1 cm

  • 55

    Blood production outside the bone marrow:

    EXTRAmedullary hematopoiesis

  • 56

    Hematopoietic stem cell marker:

    CD 34

  • 57

    Common acute lymphocytic leukemia antigen:

    CD 10

  • 58

    Test for Hemoglobin S which uses black line:

    Dithionate solubility test

  • 59

    Test for ? which uses black line: Dithionate solubility test

    Hemoglobin S

  • 60

    Test for Hemoglobin S which uses ?: Dithionate solubility test

    black line

  • 61

    Starry sky pattern under low power imparted by numerous macrophages with apoptotic debris:

    Burkitt’s lymphoma

  • 62

    Granules (tertiary granules) present in Neutrophil:

    Alkaline phosphatase

  • 63

    Screening test for fibrinolysis

    Euglobulin clot lysis time:

  • 64

    Screening test for PNH:

    Sugar water screening test

  • 65

    Screening test for ?: Sugar water screening test

    PNH

  • 66

    . Derived from RBC Histogram:

    MCV, RDW

  • 67

    Derived from Platelet Histogram:

    MPV, PDW

  • 68

    In cyanmethemoglobin method, all hemoglobin are measured, except:

    Sulfhemoglobin

  • 69

    Color of blood in sulfhemoglobinemia:

    Mauve lavender

  • 70

    Color of blood in ?: Mauve lavender

    sulfhemoglobinemia

  • 71

    Purplish red pinpoint hemorrhagic spots:

    Petechiae

  • 72

    Blood escapes into SMALL areas of skin and mucous membrane:

    Purpura

  • 73

    Blood escapes into LARGE areas of skin, mucous membrane, and other tissues:

    Ecchymosis

  • 74

    Primary hemostasis:

    Vasoconstriction

  • 75

    ? hemostasis: Vasoconstriction

    Primary

  • 76

    Outer surface of platelet:

    Glycocalyx

  • 77

    Contains microtubules that maintains platelet shape:

    Sol-gel zone

  • 78

    Platelet estimate of 100,000 to 149,000/µL:

    Slight decrease

  • 79

    Platelet estimate of ?: Slight decrease

    100,000 to 149,000/µL

  • 80

    Platelet estimate of 150,000 to 199,000/µL:

    Low normal

  • 81

    Platelet estimate of ?: Low normal

    150,000 to 199,000/µL

  • 82

    Labile factors:

    Factors V and VIII

  • 83

    Prematurely activates at cold temperature:

    Factors VII F XI

  • 84

    Vitamin K-dependent factors:

    Factors II, VII, IX, X

  • 85

    Normal value for TEMPLATE bleeding time:

    6 – 10 minutes

  • 86

    Christmas factor:

    Factor IX

  • 87

    Rosenthal syndrome: Factor ? deficiency

    Factor XI deficiency

  • 88

    ? syndrome: Factor XI deficiency

    Rosenthal

  • 89

    Platelet estimate of 401,000 to 599,000/µl:

    Slight increase

  • 90

    Platelet estimate of ?: Slight increase

    401,000 to 599,000/µl

  • 91

    Platelet estimate of 600,000 to 800,000/µL:

    Moderate increase

  • 92

    Platelet estimate of ?: Moderate increase

    600,000 to 800,000/µL

  • 93

    A surgical connection between to structures, it usually means a connection that is created between tubular structures, such as blood vessels or loops of intestines:

    ANASTOMOSIS

  • 94

    Polyclonal antibodies used in immunohistochemical techniques are frequently derived from:

    RABBIT

  • 95

    Most rapid of the common freezing agents:

    LIQUID NITROGEN

  • 96

    General purpose fixative:

    10% neutral buffered formalin

  • 97

    Protein fixation:

    Neutral buffered formol saline or formaldehyde vapor

  • 98

    : Neutral buffered formol saline or formaldehyde vapor

    Protein fixation

  • 99

    Fixatives for nucleic acids:

    Ethanol, methanol and Carnoy’s solution

  • 100

    Amount of fixative used has been ? times the volume of tissue to be fixed. Recently, the maximum effectiveness of fixation is noted to be 20 times the tissue volume

    10 to 25

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    Protein A: (2)

    Staphylococcus aureus, coagglutination

  • 2

    Slime layer production:

    Staphylococcus epidermidis

  • 3

    Protein ?: Streptococcus pyogenes

    M

  • 4

    Protein M: ?

    Streptococcus pyogenes

  • 5

    Colonies with ground glass appearance: ? (Mahon)

    Legionella

  • 6

    Increased resistance of Pseudomonas aeruginosa to aminoglycosides: Increased ? and ?

    calcium and magnesium

  • 7

    Increased resistance of ? to aminoglycosides: Increased calcium and magnesium

    Pseudomonas aeruginosa

  • 8

    Increased resistance of Pseudomonas aeruginosa to ?: Increased calcium and magnesium

    aminoglycosides

  • 9

    Smallest free-living organism:

    Mycoplasma

  • 10

    . : Comparison with peers

    Benchmarking

  • 11

    Histoplasma crossreacts with:

    BAC Blastomyces, Aspergillus and Coccidioides

  • 12

    Aman medium stain:

    Lactophenol cotton blue

  • 13

    ? stain: Lactophenol cotton blue

    Aman medium

  • 14

    Czapek’s medium: Isolation of ?

    Aspergillus

  • 15

    ? medium: Isolation of Aspergillus

    Czapek’s

  • 16

    African histoplasmosis:

    Histoplasma duboisii

  • 17

    : Histoplasma duboisii

    African histoplasmosis

  • 18

    Test for Candida albicans that uses serum:

    Germ tube test

  • 19

    Test for ? that uses serum: Germ tube test

    Candida albicans

  • 20

    Chlamydospore production of Candida albicans:

    Cornmeal agar

  • 21

    Chlamydospore production of ? Cornmeal agar

    Candida albicans:

  • 22

    ? production of Candida albicans: Cornmeal agar

    Chlamydospore

  • 23

    Candidiasis infection affecting the oral cavity:

    Thrush

  • 24

    ? infection affecting the oral cavity: Thrush

    Candidiasis

  • 25

    General isolation media for fungi:

    Saboraud’s dextrose agar

  • 26

    General isolation media for ?: Saboraud’s dextrose agar

    fungi

  • 27

    Major biologic hazard to laboratory personnel: ?

    Coccidioides immitis

  • 28

    Sensitive fungal (fluorescent) dye that binds to cell wall:

    Calcofluor white

  • 29

    Chromoblastomycosis:

    Sclerotic bodies

  • 30

    : Sclerotic bodies

    Chromoblastomycosis

  • 31

    Rose gardener’s disease:

    Sporotrichosis

  • 32

    Eosinophilic material due to antigen-antibody reaction in cases of sporotrichosis:

    Asteroid body

  • 33

    Largest DNA virus:

    Poxvirus

  • 34

    Smallest DNA virus:

    Parvovirus

  • 35

    Largest RNA virus:

    Paramyxovirus

  • 36

    . Smallest RNA virus:

    Enterovirus (Picornaviridae)

  • 37

    Cross reactive antigen in all human adenoviruses:

    Hexon

  • 38

    Gastroenteritis in children during winter months:

    Rotavirus

  • 39

    Nonbacterial gastroenteritis in adults:

    Norovirus

  • 40

    Toxic to HSV:

    Calcium alginate

  • 41

    Isolation medium for Cytomegalovirus:

    Human fibroblast cells

  • 42

    True amoeba:

    GENUS Entamoeba

  • 43

    Trophozoite with ingested red blood cell:

    Entamoeba histolytica

  • 44

    Trophozoite with ingested WBC:

    Entamoeba gingivalis

  • 45

    . Gay bowel syndrome:

    Giardiasis

  • 46

    Cercaria minus a tail:

    Schistosomule

  • 47

    Infective stage of Diphyllobothrium latum:

    Plerocercoid larva

  • 48

    . Resembles Diphyllobothrium latum adult:

    Spirometra

  • 49

    Passing of proglottids of Taenia: Irritated by ?

    ALCOHOL

  • 50

    ?. eggs: Hexacanth embryo with thick radial striations

    Taenia spp

  • 51

    Cercarial dermatitis: ?

    Schistosomes

  • 52

    Length of needle in routine phlebotomy:

    1.0 – 1.5 inches

  • 53

    Angle of draw in venipuncture:

    15 to 30 ° angle (15 degree angle)

  • 54

    The distance of drop of blood from the edge of the slide:

    1 cm

  • 55

    Blood production outside the bone marrow:

    EXTRAmedullary hematopoiesis

  • 56

    Hematopoietic stem cell marker:

    CD 34

  • 57

    Common acute lymphocytic leukemia antigen:

    CD 10

  • 58

    Test for Hemoglobin S which uses black line:

    Dithionate solubility test

  • 59

    Test for ? which uses black line: Dithionate solubility test

    Hemoglobin S

  • 60

    Test for Hemoglobin S which uses ?: Dithionate solubility test

    black line

  • 61

    Starry sky pattern under low power imparted by numerous macrophages with apoptotic debris:

    Burkitt’s lymphoma

  • 62

    Granules (tertiary granules) present in Neutrophil:

    Alkaline phosphatase

  • 63

    Screening test for fibrinolysis

    Euglobulin clot lysis time:

  • 64

    Screening test for PNH:

    Sugar water screening test

  • 65

    Screening test for ?: Sugar water screening test

    PNH

  • 66

    . Derived from RBC Histogram:

    MCV, RDW

  • 67

    Derived from Platelet Histogram:

    MPV, PDW

  • 68

    In cyanmethemoglobin method, all hemoglobin are measured, except:

    Sulfhemoglobin

  • 69

    Color of blood in sulfhemoglobinemia:

    Mauve lavender

  • 70

    Color of blood in ?: Mauve lavender

    sulfhemoglobinemia

  • 71

    Purplish red pinpoint hemorrhagic spots:

    Petechiae

  • 72

    Blood escapes into SMALL areas of skin and mucous membrane:

    Purpura

  • 73

    Blood escapes into LARGE areas of skin, mucous membrane, and other tissues:

    Ecchymosis

  • 74

    Primary hemostasis:

    Vasoconstriction

  • 75

    ? hemostasis: Vasoconstriction

    Primary

  • 76

    Outer surface of platelet:

    Glycocalyx

  • 77

    Contains microtubules that maintains platelet shape:

    Sol-gel zone

  • 78

    Platelet estimate of 100,000 to 149,000/µL:

    Slight decrease

  • 79

    Platelet estimate of ?: Slight decrease

    100,000 to 149,000/µL

  • 80

    Platelet estimate of 150,000 to 199,000/µL:

    Low normal

  • 81

    Platelet estimate of ?: Low normal

    150,000 to 199,000/µL

  • 82

    Labile factors:

    Factors V and VIII

  • 83

    Prematurely activates at cold temperature:

    Factors VII F XI

  • 84

    Vitamin K-dependent factors:

    Factors II, VII, IX, X

  • 85

    Normal value for TEMPLATE bleeding time:

    6 – 10 minutes

  • 86

    Christmas factor:

    Factor IX

  • 87

    Rosenthal syndrome: Factor ? deficiency

    Factor XI deficiency

  • 88

    ? syndrome: Factor XI deficiency

    Rosenthal

  • 89

    Platelet estimate of 401,000 to 599,000/µl:

    Slight increase

  • 90

    Platelet estimate of ?: Slight increase

    401,000 to 599,000/µl

  • 91

    Platelet estimate of 600,000 to 800,000/µL:

    Moderate increase

  • 92

    Platelet estimate of ?: Moderate increase

    600,000 to 800,000/µL

  • 93

    A surgical connection between to structures, it usually means a connection that is created between tubular structures, such as blood vessels or loops of intestines:

    ANASTOMOSIS

  • 94

    Polyclonal antibodies used in immunohistochemical techniques are frequently derived from:

    RABBIT

  • 95

    Most rapid of the common freezing agents:

    LIQUID NITROGEN

  • 96

    General purpose fixative:

    10% neutral buffered formalin

  • 97

    Protein fixation:

    Neutral buffered formol saline or formaldehyde vapor

  • 98

    : Neutral buffered formol saline or formaldehyde vapor

    Protein fixation

  • 99

    Fixatives for nucleic acids:

    Ethanol, methanol and Carnoy’s solution

  • 100

    Amount of fixative used has been ? times the volume of tissue to be fixed. Recently, the maximum effectiveness of fixation is noted to be 20 times the tissue volume

    10 to 25